| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 16 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 16 |
| 2 | TACROLIMUS OINTMENT 0.1% | 16 |
| 3 | PREDNISONE | 13 |
| 4 | EVEROLIMUS | 10 |
| 5 | EVEROLIMUS TABLETS | 10 |
| 6 | DOXORUBICIN | 9 |
| 7 | TESTOSTERONE | 9 |
| 8 | AZATHIOPRINE | 6 |
| 9 | CARMUSTINE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 6 | 0.0039 |
| 1 | CARMUSTINE | 6 | 0.0013 |
| 2 | VELAGLUCERASE ALFA | 2 | 0.0010 |
| 3 | EVEROLIMUS TABLETS | 10 | 0.0006 |
| 4 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 5 | TESTOSTERONE | 9 | 0.0004 |
| 6 | SIROLIMUS | 4 | 0.0003 |
| 7 | MELPHALAN HYDROCHLORIDE | 6 | 0.0002 |
| 8 | EVEROLIMUS | 10 | 0.0002 |
| 9 | MYCOPHENILIC ACID | 4 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 17 |
| 1 | Kinase Inhibitor [EPC] | 13 |
| 2 | mTOR Inhibitor Immunosuppressant [EPC] | 10 |
| 3 | Alkylating Drug [EPC] | 9 |
| 4 | Androgen [EPC] | 9 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 6 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| 7 | Purine Antimetabolite [EPC] | 6 |
| 8 | Topoisomerase Inhibitor [EPC] | 6 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen [EPC] | 9 | 0.0003 |
| 1 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 4 | Vitamin K [EPC] | 1 | 0.0001 |
| 5 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 8 | Purine Antimetabolite [EPC] | 6 | 0.0001 |
| 9 | Complement Inhibitor [EPC] | 3 | 0.0001 |